Common Stock, Shares, Outstanding of Tracon Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tracon Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Jun 2024.
  • Tracon Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 3,407,564, a 87% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Tracon Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 3,407,564 -23,222,029 -87% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 2,662,507 -21,365,384 -89% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 2,285,818 -20,839,432 -90% 31 Dec 2023 10-Q 13 Aug 2024 2024 Q2
Q3 2023 31,130,335 +9,380,411 +43% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 26,629,593 +5,207,795 +24% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 24,027,891 +4,400,931 +22% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 23,125,250 +3,679,347 +19% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 21,749,924 +2,319,555 +12% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 21,421,798 +5,919,834 +38% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 19,626,960 +4,146,149 +27% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 19,445,903 +3,967,116 +26% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 19,430,369 +5,747,716 +42% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 15,501,964 +7,728,149 +99% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 15,480,811 +11,429,624 +282% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 15,478,787 +11,427,600 +282% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 13,682,653 -16,254,804 -54% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 7,773,815 -22,163,642 -74% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 4,051,187 -25,847,511 -86% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 4,051,187 +1,064,005 +36% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 29,937,457 +96,613 +0.32% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 29,937,457 +107,859 +0.36% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 29,898,698 +1,457,163 +5.1% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 2,987,182 -14,724,746 -83% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 29,840,844 +12,447,788 +72% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 29,829,598 +13,173,681 +79% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 28,441,535 +11,857,928 +72% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 17,711,928 +1,627,207 +10% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 17,393,056 +4,336,803 +33% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 16,655,917 +4,452,031 +36% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 16,583,607 +4,398,365 +36% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 16,084,721 +3,908,779 +32% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 13,056,253 +895,320 +7.4% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 12,203,886 +100,465 +0.83% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 12,185,242 +81,821 +0.68% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 12,175,942 +10,542,088 +645% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 12,160,933 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 12,103,421 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 12,103,421 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 1,633,854 31 Dec 2014 10-K 19 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.